Interferon for people with lamivudine-resistant chronic hepatitis B virus infection

To evaluate the benefits and harms of interferon in people with lamivudine-resistant chronic hepatitis B virus infection.

This is a protocol.

Health topics:

Published:

7 April 2016

Authors:

Mok S, Mohan S, Hunter KM, Wang YR, Judge TA

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Mok S, Mohan S, Hunter KM, Wang YR, Judge TA. Interferon for people with lamivudine-resistant chronic hepatitis B virus infection. Cochrane Database of Systematic Reviews 2016, Issue 4. Art. No.: CD012138. DOI: 10.1002/14651858.CD012138